Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Jones

Showing results (1391-1400 of 3,162) with videos related to

Pageof 317
Sort By:
Diagnostic Microbiology and Infectious Disease|February 20, 2004
Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolatesJennifer M Streit, Thomas R Fritsche, Helio S Sader, et al.
International Journal of Antimicrobial Agents|December 29, 2004
Cefdinir activity against contemporary North American isolates from community-acquired urinary tract infectionsHelio S Sader, Douglas J Biedenbach, Jennifer M Streit, et al.
Gene|August 19, 2004
Genomic organisation of the human MDM2 oncogene and relationship to its alternatively spliced mRNAsHuiling Liang, Helen Atkins, Rana Abdel-Fattah, et al.
Biosensors & Bioelectronics|January 1, 1995
The characterization of liposomal glucose oxidase electrodes for the measurement of glucoseM A Taylor, M N Jones, P M Vadgama, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1994
Prediction of piperacillin-tazobactam susceptibility among Enterobacteriaceae, Pseudomonas aeruginosa, and other bacteria using ticarcillin-clavulanic acid, ceftazidime, and other broad-spectrum antimicrobial in vitro test resultsR N Jones, L D Sutton, H F Cantrell, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1994
Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone Resistance Surveillance GroupR N Jones, E N Kehrberg, M E Erwin, et al.
Journal of Chemotherapy (Florence, Italy)|December 6, 2005
Comparative antimicrobial potency of meropenem tested against Gram-negative bacilli: report from the MYSTIC surveillance program in the United States (2004)P R Rhomberg, T R Fritsche, H S Sader, et al.
Journal of Chemotherapy (Florence, Italy)|December 6, 2005
Daptomycin in vitro activity tested against Gram-positive strains collected from European and Latin American medical centers in 2003H S Sader, T R Fritsche, J M Streit, et al.
Diagnostic Microbiology and Infectious Disease|October 1, 1993
Interlaboratory variations of fluoroquinolone susceptibility testing. An international study to validate the quality of microbiology results reported during the fleroxacin clinical trialsR N Jones, M E Erwin, H L Hager, et al.
Diagnostic Microbiology and Infectious Disease|August 18, 2005
Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unitHelio S Sader, Ronald N Jones, Michael J Dowzicky, et al.
Pageof 317

Showing results (1391-1400 of 3,162) with videos related to

Sort By:
Pageof 317
Diagnostic Microbiology and Infectious Disease|February 20, 2004
Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolatesJennifer M Streit, Thomas R Fritsche, Helio S Sader, et al.
International Journal of Antimicrobial Agents|December 29, 2004
Cefdinir activity against contemporary North American isolates from community-acquired urinary tract infectionsHelio S Sader, Douglas J Biedenbach, Jennifer M Streit, et al.
Gene|August 19, 2004
Genomic organisation of the human MDM2 oncogene and relationship to its alternatively spliced mRNAsHuiling Liang, Helen Atkins, Rana Abdel-Fattah, et al.
Biosensors & Bioelectronics|January 1, 1995
The characterization of liposomal glucose oxidase electrodes for the measurement of glucoseM A Taylor, M N Jones, P M Vadgama, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1994
Prediction of piperacillin-tazobactam susceptibility among Enterobacteriaceae, Pseudomonas aeruginosa, and other bacteria using ticarcillin-clavulanic acid, ceftazidime, and other broad-spectrum antimicrobial in vitro test resultsR N Jones, L D Sutton, H F Cantrell, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1994
Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone Resistance Surveillance GroupR N Jones, E N Kehrberg, M E Erwin, et al.
Journal of Chemotherapy (Florence, Italy)|December 6, 2005
Comparative antimicrobial potency of meropenem tested against Gram-negative bacilli: report from the MYSTIC surveillance program in the United States (2004)P R Rhomberg, T R Fritsche, H S Sader, et al.
Journal of Chemotherapy (Florence, Italy)|December 6, 2005
Daptomycin in vitro activity tested against Gram-positive strains collected from European and Latin American medical centers in 2003H S Sader, T R Fritsche, J M Streit, et al.
Diagnostic Microbiology and Infectious Disease|October 1, 1993
Interlaboratory variations of fluoroquinolone susceptibility testing. An international study to validate the quality of microbiology results reported during the fleroxacin clinical trialsR N Jones, M E Erwin, H L Hager, et al.
Diagnostic Microbiology and Infectious Disease|August 18, 2005
Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unitHelio S Sader, Ronald N Jones, Michael J Dowzicky, et al.
Pageof 317